Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Genetics
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues

Share

June 2015; 1 (1) ArticleOpen Access

Genetic analysis for a shared biological basis between migraine and coronary artery disease

Bendik S. Winsvold, Christopher P. Nelson, Rainer Malik, Padhraig Gormley, Verneri Anttila, Jason Vander Heiden, Katherine S. Elliott, Line M. Jacobsen, Priit Palta, Najaf Amin, Boukje de Vries, Eija Hämäläinen, Tobias Freilinger, M. Arfan Ikram, Thorsten Kessler, Markku Koiranen, Lannie Ligthart, George McMahon, Linda M. Pedersen, Christina Willenborg, Hong-Hee Won, Jes Olesen, Ville Artto, Themistocles L. Assimes, Stefan Blankenberg, Dorret I. Boomsma, Lynn Cherkas, George Davey Smith, Stephen E. Epstein, Jeanette Erdmann, Michel D. Ferrari, Hartmut Göbel, Alistair S. Hall, Marjo-Riitta Jarvelin, Mikko Kallela, Jaakko Kaprio, Sekar Kathiresan, Terho Lehtimäki, Ruth McPherson, Winfried März, Dale R. Nyholt, Christopher J. O'Donnell, Lydia Quaye, Daniel J. Rader, Olli Raitakari, Robert Roberts, Heribert Schunkert, Markus Schürks, Alexandre F.R. Stewart, Gisela M. Terwindt, Unnur Thorsteinsdottir, Arn M.J.M. van den Maagdenberg, Cornelia van Duijn, Maija Wessman, Tobias Kurth, Christian Kubisch, Martin Dichgans, Daniel I. Chasman, Chris Cotsapas, John-Anker Zwart, Nilesh J. Samani, Aarno Palotie, For the CARDIoGRAM Consortium and the International Headache Genetics Consortium
First published July 2, 2015, DOI: https://doi.org/10.1212/NXG.0000000000000010
Bendik S. Winsvold
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher P. Nelson
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rainer Malik
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Padhraig Gormley
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Verneri Anttila
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Vander Heiden
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine S. Elliott
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Line M. Jacobsen
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Priit Palta
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Najaf Amin
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boukje de Vries
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eija Hämäläinen
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Freilinger
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Arfan Ikram
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thorsten Kessler
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markku Koiranen
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lannie Ligthart
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George McMahon
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda M. Pedersen
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Willenborg
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong-Hee Won
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jes Olesen
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ville Artto
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Themistocles L. Assimes
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Blankenberg
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorret I. Boomsma
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynn Cherkas
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Davey Smith
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen E. Epstein
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanette Erdmann
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel D. Ferrari
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hartmut Göbel
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alistair S. Hall
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjo-Riitta Jarvelin
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikko Kallela
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaakko Kaprio
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sekar Kathiresan
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terho Lehtimäki
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth McPherson
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winfried März
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dale R. Nyholt
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher J. O'Donnell
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lydia Quaye
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Rader
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olli Raitakari
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Roberts
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heribert Schunkert
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schürks
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandre F.R. Stewart
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gisela M. Terwindt
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Unnur Thorsteinsdottir
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arn M.J.M. van den Maagdenberg
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelia van Duijn
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maija Wessman
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Kurth
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Kubisch
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Dichgans
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel I. Chasman
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Cotsapas
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John-Anker Zwart
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nilesh J. Samani
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aarno Palotie
Author affiliations are provided at the end of the article.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Author affiliations are provided at the end of the article.
Full PDF
Citation
Genetic analysis for a shared biological basis between migraine and coronary artery disease
Bendik S. Winsvold, Christopher P. Nelson, Rainer Malik, Padhraig Gormley, Verneri Anttila, Jason Vander Heiden, Katherine S. Elliott, Line M. Jacobsen, Priit Palta, Najaf Amin, Boukje de Vries, Eija Hämäläinen, Tobias Freilinger, M. Arfan Ikram, Thorsten Kessler, Markku Koiranen, Lannie Ligthart, George McMahon, Linda M. Pedersen, Christina Willenborg, Hong-Hee Won, Jes Olesen, Ville Artto, Themistocles L. Assimes, Stefan Blankenberg, Dorret I. Boomsma, Lynn Cherkas, George Davey Smith, Stephen E. Epstein, Jeanette Erdmann, Michel D. Ferrari, Hartmut Göbel, Alistair S. Hall, Marjo-Riitta Jarvelin, Mikko Kallela, Jaakko Kaprio, Sekar Kathiresan, Terho Lehtimäki, Ruth McPherson, Winfried März, Dale R. Nyholt, Christopher J. O'Donnell, Lydia Quaye, Daniel J. Rader, Olli Raitakari, Robert Roberts, Heribert Schunkert, Markus Schürks, Alexandre F.R. Stewart, Gisela M. Terwindt, Unnur Thorsteinsdottir, Arn M.J.M. van den Maagdenberg, Cornelia van Duijn, Maija Wessman, Tobias Kurth, Christian Kubisch, Martin Dichgans, Daniel I. Chasman, Chris Cotsapas, John-Anker Zwart, Nilesh J. Samani, Aarno Palotie, For the CARDIoGRAM Consortium and the International Headache Genetics Consortium
Neurol Genet Jun 2015, 1 (1) e10; DOI: 10.1212/NXG.0000000000000010

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1247

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 1 no. 1 e10
DOI: 
https://doi.org/10.1212/NXG.0000000000000010

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2376-7839
History: 
  • Received April 4, 2015
  • Accepted in final form May 27, 2015
  • First Published July 2, 2015.

Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Disclosures

    1. Bendik S. Winsvold, MD*,
    2. Christopher P. Nelson, PhD*,
    3. Rainer Malik, PhD,
    4. Padhraig Gormley, PhD,
    5. Verneri Anttila, PhD,
    6. Jason Vander Heiden, MSc,
    7. Katherine S. Elliott, PhD,
    8. Line M. Jacobsen, PhD,
    9. Priit Palta, PhD,
    10. Najaf Amin, PhD,
    11. Boukje de Vries, PhD,
    12. Eija Hämäläinen, BS,
    13. Tobias Freilinger, MD,
    14. M. Arfan Ikram, MD,
    15. Thorsten Kessler, MD,
    16. Markku Koiranen, MS,
    17. Lannie Ligthart, PhD,
    18. George McMahon, PhD,
    19. Linda M. Pedersen, PhD,
    20. Christina Willenborg, PhD,
    21. Hong-Hee Won, PhD,
    22. Jes Olesen, PhD,
    23. Ville Artto, MD,
    24. Themistocles L. Assimes, PhD,
    25. Stefan Blankenberg, MD,
    26. Dorret I. Boomsma, PhD,
    27. Lynn Cherkas, PhD,
    28. George Davey Smith, Dsc,
    29. Stephen E. Epstein, MD,
    30. Jeanette Erdmann, PhD,
    31. Michel D. Ferrari, PhD,
    32. Hartmut Göbel, PhD,
    33. Alistair S. Hall, PhD,
    34. Marjo-Riitta Jarvelin, PhD,
    35. Mikko Kallela, PhD,
    36. Jaakko Kaprio, PhD,
    37. Sekar Kathiresan, MD,
    38. Terho Lehtimäki, MD,
    39. Ruth McPherson, PhD,
    40. Winfried März, PhD,
    41. Dale R. Nyholt, PhD,
    42. Christopher J. O'Donnell, MD,
    43. Lydia Quaye, PhD,
    44. Daniel J. Rader, MD,
    45. Olli Raitakari, PhD,
    46. Robert Roberts, MD,
    47. Heribert Schunkert, MD,
    48. Markus Schürks, MD,
    49. Alexandre F.R. Stewart, PhD,
    50. Gisela M. Terwindt, PhD,
    51. Unnur Thorsteinsdottir, PhD,
    52. Arn M.J.M. van den Maagdenberg, PhD,
    53. Cornelia van Duijn, PhD,
    54. Maija Wessman, PhD,
    55. Tobias Kurth, MD,
    56. Christian Kubisch, MD,
    57. Martin Dichgans, MD,
    58. Daniel I. Chasman, PhD,
    59. Chris Cotsapas, PhD,
    60. John-Anker Zwart, MD,
    61. Nilesh J. Samani, FRCP,
    62. Aarno Palotie, MD;
    63. For the CARDIoGRAM Consortium and the International Headache Genetics Consortium
  1. Bendik S. Winsvold, MD*,
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. The Research Council of Norway, grant no. 231187/F20, (2) the South-Eastern Norway Regional Health Authority (grant number 2010075 and 2011083.

    Research Support, Academic Entities:
    1. Forsbergs og Aulies legat

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  3. Christopher P. Nelson, PhD*,
  4. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  5. Rainer Malik, PhD,
  6. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  7. Padhraig Gormley, PhD,
  8. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  9. Verneri Anttila, PhD,
  10. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. Orion Farmos Research Foundation

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  11. Jason Vander Heiden, MSc,
  12. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. Travel funding from New England Biolabs to speak regarding immunoglobulin repertoire sequencing at the 2014 American Society of Human Genetics annual meeting.

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. National Library of Medicine, T15 LM07056, 2012-2015.

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. United States-Israel Binational Science Foundation grant 2013395.

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  13. Katherine S. Elliott, PhD,
  14. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  15. Line M. Jacobsen, PhD,
  16. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. (1) AstraZeneca, Medical Advisor, past 4mnths. Just recently left academia and started in a commercial entity. Not considered relevant to the work of to this article as all my contribution was performed prior to starting in a commercial entity

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  17. Priit Palta, PhD,
  18. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. (1) Personal research grant from the Finnish Cultural Foundation.

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  19. Najaf Amin, PhD,
  20. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. Netherlands Brain Foundation. grant number F2013(1)-28)

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  21. Boukje de Vries, PhD,
  22. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  23. Eija Hämäläinen, BS,
  24. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  25. Tobias Freilinger, MD,
  26. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. (1) Speaker honoraria from Boehringer Ingelheim (2) Speaker honoraria from Allergan

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. (1) Deutsche Forschungsgemeinschaft (DFG), grant number FR3324/2-1, PI

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  27. M. Arfan Ikram, MD,
  28. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. (1) Kaizo ltd, speaker honorarium

    Editorial Boards:
    1. (1) Neuroepidemiology, Editorial Board Member, 2011-2015, (2) PLoS One, Academic Editor, 2013-2015, (3) Journal of Alzheimer Disease, Academic Editor, 2015

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. (1) Janssen Prevention Center

    Research Support, Government Entities:
    1. (1) Netherlands Organization for Health Research and Development (ZonMW: 916.13.054)

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. (1) the Netherlands Heart Foundation (2009B102 and 2012T008), (2) Internationaal Parkinson Fonds, (3) Internationale Stichting Alzheimer Onderzoek (#12533), (4) Alzheimer Association

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  29. Thorsten Kessler, MD,
  30. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  31. Markku Koiranen, MS,
  32. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  33. Lannie Ligthart, PhD,
  34. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. EFIC-Grünenthal Grant

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  35. George McMahon, PhD,
  36. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  37. Linda M. Pedersen, PhD,
  38. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  39. Christina Willenborg, PhD,
  40. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  41. Hong-Hee Won, PhD,
  42. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  43. Jes Olesen, PhD,
  44. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. (1) Jannsen Pharmaceutical Products

    Speakers' Bureaus:
    1. (1) Allergan

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  45. Ville Artto, MD,
  46. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. funding for a trip from (1) Boehringer Ingelheim, ESC, 2007 (2) Orion, 2008, EFNS (3) Menarini, 2008, Migraine trust (4) Bayer, 2009, AAN

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. (1) the Finnish Medical Foundation, 2008 (2) Helsinki University Central Hospital, 2008

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  47. Themistocles L. Assimes, PhD,
  48. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Frontiers in Cardiovascular Medicine, Associate Editor

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. Telomere Diagnostics, Inc.

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. 1) Telomere Diagnostics, Inc.

    Research Support, Government Entities:
    1. 1) NIDDK, DK088942, PI, 2011-2015 2) NHLBI, HHSN268201300006C, co-PI, 2013-2015

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  49. Stefan Blankenberg, MD,
  50. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  51. Dorret I. Boomsma, PhD,
  52. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  53. Lynn Cherkas, PhD,
  54. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  55. George Davey Smith, Dsc,
  56. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  57. Stephen E. Epstein, MD,
  58. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. CardioCell For work relating to stem cell therapy for cardiovascular disease

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. MedStar Heart and Vascular Institute, MedStar Washington Hospital Center

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. CardioCell For work relating to stem cell therapy for cardiovascular disease

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. CardioCell For work relating to stem cell therapy for cardiovascular disease

    Stock/Stock Options, Medical Equipment & Materials:
    1. CardioCell For work relating to stem cell therapy for cardiovascular disease

    Legal Proceedings:
    1. NONE

  59. Jeanette Erdmann, PhD,
  60. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  61. Michel D. Ferrari, PhD,
  62. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Cephalalgia, associate editor

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. (1) Medtronic

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. (1) Netherlands Organization for Scientific Research (NWO) (2) European Community (3) ZonMW

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. (1) Dutch Heart Foundation

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  63. Hartmut Göbel, PhD,
  64. Scientific Advisory Boards:
    1. Allergan, Bayer Vital, St. Jude Medical

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. Amgen, Allergan, Hormosan, Klosterfrau, MSD, Mundipharma, St. Jude Medical, Teva

    Editorial Boards:
    1. Der Schmerz, Pain Research and Treatment

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. Allergan, Hormosan, Klosterfrau, MSD, Mundipharma, St. Jude Medical, Teva

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. St. Jude Medical

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  65. Alistair S. Hall, PhD,
  66. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  67. Marjo-Riitta Jarvelin, PhD,
  68. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  69. Mikko Kallela, PhD,
  70. Scientific Advisory Boards:
    1. Advisory Board for MSD (terminated in 2011), Advisory Board for Allergan (terminated in 2013)

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. MSD, a scientific meeting, 2009, 2010, 2011 Allergan, a scientific meeting 2011 TEVA, a scientific meeting 2012 Novartis, a scientific meeting 2013 Genzyme, a scientific meeting 2014 Novartis, a scientific meeting 2015

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. Compensation for producing educational material TEVA (MS educational program) 2012 Allergan (chronic migraine educational program 2013)

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. Helsinki University Central Hospital, funded for research, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. Helsinki Headache Center, hold stock, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  71. Jaakko Kaprio, PhD,
  72. Scientific Advisory Boards:
    1. D-tect project, PI professor Berit Heitmann, Copenhagen University, non-profit

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. 1) Pfizer Ltd, speaker honorarium 2012

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. Pfizer Ltd, Pharmacogenetics of smoking cessation, 2011-2014

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  73. Sekar Kathiresan, MD,
  74. Scientific Advisory Boards:
    1. (1) Regeneron (2) Merck (3) Eli Lilly (4) Aegerion (5) Catabasis (6) Amarin (7) Novartis

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. (1) Regeneron (2) Aegerion (3) Merck

    Research Support, Government Entities:
    1. (1) NIH

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. (1) Fondation Leducq

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  75. Terho Lehtimäki, MD,
  76. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  77. Ruth McPherson, PhD,
  78. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Arteriosclerosis, Thrombosis & Vascular Biology, Associate Editor 2008 - present

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. Amgen AstraZeneca Johnson & johnson Sanofi

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. 10/2014 – 09/2019. R McPherson, K Rayner, ME Harper, R Dent. Molecular Basis of Weight Loss Variability in Response to Energy Restriction. Canadian Institutes of Health Research #MOP-136936, $170,688 p.a. 04/2014 – 04/2015. R McPherson, K Rayner, ME Harper, R Dent. Molecular Basis of Weight Loss Variability in Response to Energy Restriction. Canadian Institutes of Health Research # OPB – 134211. $100,000 07/2014 – 07/2015. R McPherson: Genotype to phenotype: functional analysis of CHD genetic variants Heart & Stroke Foundation of Canada. BR-7519, $70,000

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  79. Winfried März, PhD,
  80. Scientific Advisory Boards:
    1. (1) Aegerion Pharmaceuticals (2) AMGEN (3) Danone Research (4) Sanofi/Genzyme (5) Hoffmann LaRoche (6) MSD (7) Synageva (8) Lilly (9) BASF

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. (1) Aegerion Pharmaceuticals (2) AMGEN (3) Danone Research (4) Sanofi/Genzyme (5) Hoffmann LaRoche (6) MSD (7) Synageva (8) Lilly (9) BASF

    Editorial Boards:
    1. (1) Europoean Heart Journal (2) Journal of Laboratory Medicine

    Patents:
    1. (!) International application PCT/EP2011/051957 (published as WO 2011/098519) Date of submission: 10.02.2011

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. Synlab Services GmbH

    Consultancies:
    1. see list in 1

    Speakers' Bureaus:
    1. see list in 1

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. see list in 1.

    Research Support, Government Entities:
    1. (1) European Union (2) German Ministry of Research (3) German Ministry of Commerce (4) Wissenschaftsinitiative Oberrhein

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. Synlab Holding GmbH

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. Synlab Holding GmbH

    Legal Proceedings:
    1. NONE

  81. Dale R. Nyholt, PhD,
  82. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  83. Christopher J. O'Donnell, MD,
  84. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. As an employee of the Division of Intramural Research of the National Heart, Lung and Blood Institute of the US National Institutes of Health, I am a full time employee of the Department of Health and Human Services of the US Government.

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  85. Lydia Quaye, PhD,
  86. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  87. Daniel J. Rader, MD,
  88. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. ATVB, deputy editor

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. National Institutes of Health

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. Leducq Fondation

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  89. Olli Raitakari, PhD,
  90. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  91. Robert Roberts, MD,
  92. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  93. Heribert Schunkert, MD,
  94. Scientific Advisory Boards:
    1. AstraZeneca, Grant, Honoraria, Constuling Fee, Commercial entity AMGEN, Grant, Honoraria, Constuling Fee, Commercial entity MSD SHARP & DOHME, Grant, Honoraria, Constuling Fee, Commercial enttity

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. AstraZeneca, Grant, Consulting Fee, Honoraria, commercial entity Bayer Vital, Grant, Consulting Fee, Honoraria, commercial entity Boehringer Ingelheim, Grant, Consulting Fee, Honoraria, commercial entity Medtronic, Grant, Consulting Fee, Honoraria, commercial entity MSD SHARP & DOHME, Grant, Consulting Fee, Honoraria, commercial entity Novartis, Grant, Consulting Fee, Honoraria, commercial entity Pfizer, Grant, Consulting Fee, Honoraria, commercial entity Sanofi-Aventis, Grant, Consulting Fee, Honoraria, commercial entity St. Jude, Grant, Consulting Fee, Honoraria, commercial entity Boston Scientific, Grant, Consulting Fee, Honoraria, commercial entity Daiichi Sankyo, Grant, Consulting Fee, Honoraria, commercial entity

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. AstraZeneca, Grant, Honoraria, Constuling Fee, Commercial enttity AMGEN, Grant, Honoraria, Constuling Fee, Commercial enttity MSD SHARP & DOHME, Grant, Honoraria, Constuling Fee, Commercial enttity

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. AstraZeneca, Grant, Consulting Fee, Honoraria, commercial entity Bayer Vital, Grant, Consulting Fee, Honoraria, commercial entity Boehringer Ingelheim, Grant, Consulting Fee, Honoraria, commercial entity Medtronic, Grant, Consulting Fee, Honoraria, commercial entity MSD SHARP & DOHME, Grant, Consulting Fee, Honoraria, commercial entity Novartis, Grant, Consulting Fee, Honoraria, commercial entity Pfizer, Grant, Consulting Fee, Honoraria, commercial entity Sanofi-Aventis, Grant, Consulting Fee, Honoraria, commercial entity St. Jude, Grant, Consulting Fee, Honoraria, commercial entity Boston Scientific, Grant, Consulting Fee, Honoraria, commercial entity Daiichi Sankyo, Grant, Consulting Fee, Honoraria, commercial entity

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  95. Markus Schürks, MD,
  96. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. (1) The Journal of Headache and Pain, Advisory Board member, since 2010, (2) BMC Neurology, Associate Editor, since 2011.

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. (1) Bayer HealthCare Pharmaceuticals, full-time employee, since 2011.

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. (1) Bayer, 2014-2015

    Legal Proceedings:
    1. NONE

  97. Alexandre F.R. Stewart, PhD,
  98. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Frontiers in Cardiovascular Medicine - Cardiovascular Genetics (reviewing editor)

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  99. Gisela M. Terwindt, PhD,
  100. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. Supported by grants of the Netherlands Organisation for Scientific Research (NWO) (GMT Vidi 917-11-319), and FP7- EUROHEADPAIN-no.602633

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  101. Unnur Thorsteinsdottir, PhD,
  102. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. I am an employee of deCODE genetics/Amgen

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  103. Arn M.J.M. van den Maagdenberg, PhD,
  104. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  105. Cornelia van Duijn, PhD,
  106. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  107. Maija Wessman, PhD,
  108. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. Folkhälsan Research Foundation, Academy of Finland (grant no 139795), Medicinska Understödsföreningen Liv och Hälsa

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  109. Tobias Kurth, MD,
  110. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. (1) BMJ, consulting clinical epidemiology editor, since 2010. (2) Cephalalgia, associate editor, since 2010.

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. I have received within the last 2 years investigator- initiated research funding from the French National Research Agency and the University of Bordeaux.

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  111. Christian Kubisch, MD,
  112. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  113. Martin Dichgans, MD,
  114. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. (1) Stroke the International Journal of Stroke, editor, (2) Cerebrovascular diseases, editorial board member, (3) Journal of Neurochemistry, editor

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. (1) Bayer Vital, (2) Boehringer Ingelheim, (3) Bristol- Meyer Squibb, (4) Heel

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. (1) Wellcometrust, 03/08 following, (2) European Union (EU FP 7), investigator, 10/13-09/16, (3) German Federal Ministry of Education and Research (BMBF), investigator, 12/13-11/16, (4) European Union (EU FP 6), investigator, 03/12-02/15

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. (1) Vascular Dementia Research Foundation, (2) Corona Foundation, (3) Jackstädt Foundation

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  115. Daniel I. Chasman, PhD,
  116. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Associate editor for Arteriosclerosis, Thrombosis, and Vascular Biology 2009-. No compensation.

    Patents:
    1. NONE

    Publishing Royalties:
    1. Protein Stucture: Determination, Analysis, and Applications for Drug Discovery. (2003) Chasman ed. Marcel Dekker. New York.

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  117. Chris Cotsapas, PhD,
  118. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NINDS, R01 NS049477, analyst, 2011-2015 NIAID, U01 AI089859, site PI, 2012-2014 NIAID, U19 AI056363, site PI, 2011-2013

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. RE Children's Consortium

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  119. John-Anker Zwart, MD,
  120. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  121. Nilesh J. Samani, FRCP,
  122. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. (1) Circulation Cardiovascular Genetics 2009- Editorial Board (2) Heart 2012- Editorial Board

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. British Heart Foundation National Institute for Health Research

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  123. Aarno Palotie, MD;
  124. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. Received travel expenses and/or honoraria for lectures or educational activities not funded by industry

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. Finnish Academy, European Union NIH, NINDS

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. Juselius Foundation and Finnish Foundation for Cardiovascular Research

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  125. For the CARDIoGRAM Consortium and the International Headache Genetics Consortium
    1. Author affiliations are provided at the end of the article.
    1. Correspondence to Dr. Palotie: aarno{at}broadinstitute.org
    View Full Text

    Article usage

    Article usage: July 2015 to July 2022

    AbstractFullPdfSource
    Jul 2015989614144Highwire
    Aug 20152177618Highwire
    Sep 201531520435Highwire
    Oct 20152285635Highwire
    Nov 20151075217Highwire
    Dec 20151023519Highwire
    Jan 20161024115Highwire
    Feb 2016592221Highwire
    Mar 2016953132Highwire
    Apr 20167820232Highwire
    May 2016743510Highwire
    Jun 2016571519Highwire
    Jul 201638397Highwire
    Aug 201634245Highwire
    Sep 2016592912Highwire
    Oct 201630466Highwire
    Nov 2016481513Highwire
    Dec 201655172Highwire
    Jan 201733113Highwire
    Feb 2017441521Highwire
    Mar 201747185Highwire
    Apr 20174274Highwire
    May 201750226Highwire
    Jun 201746184Highwire
    Jul 201735205Highwire
    Aug 201737124Highwire
    Sep 20171962Highwire
    Oct 201721114Highwire
    Nov 201738397Highwire
    Dec 201716278Highwire
    Jan 2018177810Highwire
    Feb 201813382Highwire
    Mar 2018257912Highwire
    Apr 201824394Highwire
    May 201816637Highwire
    Jun 201815506Highwire
    Jul 201812566Highwire
    Aug 201810604Highwire
    Sep 2018104006Highwire
    Oct 20181719998Highwire
    Nov 201815978Highwire
    Dec 20181727712Highwire
    Jan 20191230411Highwire
    Feb 2019169911Highwire
    Mar 20192113115Highwire
    Apr 20191217314Highwire
    May 20192714118Highwire
    Jun 2019229911Highwire
    Jul 2019101565Highwire
    Aug 201992323Highwire
    Sep 2019312082Highwire
    Oct 20192425017Highwire
    Nov 20192617410Highwire
    Dec 20192412012Highwire
    Jan 2020466914Highwire
    Feb 202022589Highwire
    Mar 2020305714Highwire
    Apr 202074411Highwire
    May 20208659Highwire
    Jun 202065514Highwire
    Jul 20203416Highwire
    Aug 202006718Highwire
    Sep 202029515Highwire
    Oct 202051768Highwire
    Nov 2020624414Highwire
    Dec 202067111Highwire
    Jan 20218378Highwire
    Feb 202155210Highwire
    Mar 2021119812Highwire
    Apr 20219909Highwire
    May 202115638Highwire
    Jun 20211012612Highwire
    Jul 202197036Highwire
    Aug 2021144627Highwire
    Sep 2021123632Highwire
    Oct 2021136441Highwire
    Nov 202142836Highwire
    Dec 20219289Highwire
    Jan 202223323Highwire
    Feb 202284916Highwire
    Mar 2022125036Highwire
    Apr 202284615Highwire
    May 2022199627Highwire
    Jun 2022123810Highwire
    Jul 202281468Highwire

    Letters: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    If you are uploading a letter concerning an article:
    You must have updated your disclosures within six months: http://submit.neurology.org

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    • Article
      • Abstract
      • GLOSSARY
      • METHODS
      • RESULTS
      • DISCUSSION
      • AUTHOR AFFILIATIONS
      • AUTHOR CONTRIBUTIONS
      • STUDY FUNDING
      • DISCLOSURE
      • ACKNOWLEDGMENT
      • Footnotes
      • REFERENCES
    • Figures & Data
    • Info & Disclosures

    Topics Discussed

    • Migraine
    • Association studies in genetics

    Alert Me

    • Alert me when eletters are published
    Advertisement
    Neurology Genetics: 8 (4)

    Articles

    • Articles
    • Issues
    • Popular Articles

    About

    • About the Journals
    • Ethics Policies
    • Editors & Editorial Board
    • Contact Us
    • Advertise

    Submit

    • Author Center
    • Submit a Manuscript
    • Information for Reviewers
    • AAN Guidelines
    • Permissions

    Subscribers

    • Subscribe
    • Sign up for eAlerts
    • RSS Feed
    Site Logo
    • Visit neurology Template on Facebook
    • Follow neurology Template on Twitter
    • Visit Neurology on YouTube
    • Neurology
    • Neurology: Clinical Practice
    • Neurology: Genetics
    • Neurology: Neuroimmunology & Neuroinflammation
    • Neurology: Education
    • AAN.com
    • AANnews
    • Continuum
    • Brain & Life
    • Neurology Today

    Wolters Kluwer Logo

    Neurology: Genetics | Online ISSN: 2376-7839

    © 2022 American Academy of Neurology

    • Privacy Policy
    • Feedback
    • Advertise